Literature DB >> 28340205

Ocular involvement in patients with spondyloarthritis.

Ana Beatriz Santos Bacchiega1,2, Gustavo Guimarães Moreira Balbi1, Manuella Lima Gomes Ochtrop1,2, Francisco Assis de Andrade3, Roger Abramino Levy1,2, Xenofon Baraliakos4.   

Abstract

Ocular inflammatory diseases can present as isolated conditions but also as part of systemic inflammatory diseases. Anterior uveitis is closely related to SpA and shares the common genetic background of HLA-B27. Other ocular manifestations, such as episcleritis and scleritis, may also occur, although less frequently. Therefore, ocular involvement has been included as one of the important clinical features of SpA in the recently published classification criteria for axial and peripheral disease. However, there are a wide variety of aetiologies for ocular diseases and this must be considered in assessment of SpA.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  HLA-B27; acute anterior uveitis; ocular; spondyloarthritis; uveitis

Mesh:

Substances:

Year:  2017        PMID: 28340205     DOI: 10.1093/rheumatology/kex057

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

1.  Diagnosis of Ankylosing Spondylitis: Do not let the spine bites the eye.

Authors:  Chia Chee Chew; Ju Juen Chin; Wan Hazabbah Wan Hitam; Mei Fong Chong; Liza-Sharmini Ahmad Tajudin
Journal:  Malays Fam Physician       Date:  2021-06-04

Review 2.  The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future.

Authors:  Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Elisabetta Miserocchi; Ennio Giulio Favalli
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

3.  Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study.

Authors:  Irene E van der Horst-Bruinsma; Rianne E van Bentum; Frank D Verbraak; Atul Deodhar; Thomas Rath; Bengt Hoepken; Oscar Irvin-Sellers; Karen Thomas; Lars Bauer; Martin Rudwaleit
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-03-29       Impact factor: 5.346

Review 4.  Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review.

Authors:  Irene E van der Horst-Bruinsma; Philip C Robinson; Ennio G Favalli; Frank D Verbraak; Mindy Kim; Thomas Kumke; Lars Bauer; Bengt Hoepken; Atul Deodhar
Journal:  Rheumatol Ther       Date:  2022-09-30

5.  The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW.

Authors:  Irene van der Horst-Bruinsma; Rianne van Bentum; Frank D Verbraak; Thomas Rath; James T Rosenbaum; Maria Misterska-Skora; Bengt Hoepken; Oscar Irvin-Sellers; Brenda VanLunen; Lars Bauer; Martin Rudwaleit
Journal:  RMD Open       Date:  2020-04

6.  Non-radiographic versus radiographic axSpA: what's in a name?

Authors:  Xabier Michelena; Clementina López-Medina; Helena Marzo-Ortega
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.